Dipartimento di Medicina interna e terapia medica

• Farmacologia II - CCL Medicina e Chirurgia, Facoltà di Medicina e Chirurgia
• Farmacologia - CCL Odontoiatria e Protesi Dentaria, Facoltà di Medicina e Chirurgia
• Neuropsicofarmacologia - Scuola di specializzazione in Neuropsichiatria Infantile
• Neuropsicofarmacologia - Scuola di specializzazione in Neurologia
• Neuropsicofarmacologia - Scuola di Specializzazione in Neurofisiopatologia
• Neuropsicofarmacologia - Scuola di specializzazione in Psichiatria
• Farmacologia - Scuola di specializzazione in Farmacologia
• Farmacologia - Scuola di specializzazione in Medicina Interna
• Farmacologia - Scuola di specializzazione in Chirurgia Plastica
• Farmacologia - Scuola di specializzazione in Tossicologia
• Farmacologia - Scuola di specializzazione in Oncologia

1. BRODIE, M.J., PERUCCA, E., RYVLIN, P., BEN-MENACHEM, E., MEENCKE H.J., FOR THE LEVETIRACETAM MONOTHERAPY STUDY GROUP. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy . Neurology 2007;68: 402-408.

2. SAETRE, E., PERUCCA, E., ISOJARVI, J. and GJERSTAD, L., on behalf of the LAM 40089 Study Group. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007;48:1292-1302.

3. PERUCCA, E., FRENCH, J. and BIALER, M. Development of new antiepileptic drugs: Challenges, incentives, and recent advances. Lancet Neurol. 2007; 6:793-804.

4. PATSALOS, P.N., BERRY, D.J., BOURGEOIS, B.F.D., CLOYD, J.C., GLAUSER, T.A., JOHANNESSEN, S.I., LEPPIK, I., TOMSON, T and PERUCCA, E. Antiepileptic Drugs – Best Practice Guidelines for Therapeutic Drug Monitoring: A Position Paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-1276.

5. PERUCCA, E., CLOYD, J., CRITCHLEY, D. and FUSEAU, E. Rufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia 2008;49:1123-1141.

6. PERUCCA, E. Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions. CNS Drugs 20008;22:917-938.

7. ARZIMANOGLOU, A., FRENCH, J., BLUME, W.T., CROSS, J.H., ERNST, J.P., FEUCHT, M., GENTON, P., GUERRINI, R., KLUGER, G., PELLOCK, J.M., PERUCCA, E. and WHEELES J.W. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82-93.

8. CANEVINI, M.P., DE SARRO, G., GALIMBERTI, C.A., GATTI, G., LICCHETTA, L., MALERBA, A., MUSCAS, G., LANEVE, A., STRANO, P., and PERUCCA, E. on behalf of the SOPHIE Study Group. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010; 51:797-804

9. FATTORE, C, BONIVER, C, CAPOVILLA, G., CERMINARA, C., CITTERIO, A., COPPOLA, G., COSTA, P., DARRA, F., VECCHI M. and PERUCCA, E. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 2011;52: 802-809.

10. PERUCCA, E, TOMSON T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 10, 446-56, 2011